Global Recombinant Protein Therapeutics Cdmo Market Size & Outlook
The recombinant protein therapeutics cdmo industry worldwide is expected to reach a projected revenue of US$ 51,954.2 million by 2030. A compound annual growth rate of 13.9% is expected of the worldwide recombinant protein therapeutics cdmo industry from 2024 to 2030.
Revenue, 2023 (US$M)
$20,891.0
Forecast, 2030 (US$M)
$51,954.2
CAGR, 2024 - 2030
13.9%
Report Coverage
Worldwide
Global recombinant protein therapeutics cdmo market, 2018-2030 (US$M)
Related Markets
Global recombinant protein therapeutics cdmo market highlights
- The global recombinant protein therapeutics cdmo market generated a revenue of USD 20,891.0 million in 2023 and is expected to reach USD 51,954.2 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 13.9% by 2030.
- In terms of segment, interferons accounted for a revenue of USD 4,483.5 million in 2023.
- Growth Hormones is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 20,891.0 million |
| Market revenue in 2030 | USD 51,954.2 million |
| Growth rate | 13.9% (CAGR from 2023 to 2030) |
| Largest segment | Interferons |
| Fastest growing segment | Growth Hormones |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Growth Hormones, Interferons, Vaccines, Immunostimulating Agents |
Other key industry trends
- In terms of revenue, the North America accounted for 38.5% of the global recombinant protein therapeutics cdmo market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Kuwait is the fastest growing regional market and is projected to reach USD 107.7 million by 2030.
Interferons was the largest segment with a revenue share of 21.46% in 2023. Horizon Databook has segmented the Global recombinant protein therapeutics cdmo market based on growth hormones, interferons, vaccines, immunostimulating agents covering the revenue growth of each sub-segment from 2018 to 2030.
Can be influenced by increasing R&D activities, facility expansions, and growing disease burden. Analyzing market influencers involves innovation, acquisitions, and presence of pharmaceutical and biotech firms.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Recombinant Protein Therapeutics CDMO Market Scope
Recombinant protein therapeutics cdmo market segmentation & scope
Others
Recombinant Protein Therapeutics CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global recombinant protein therapeutics cdmo market statistics, by region, 2018-2030 (US$M)
Top 10 countries: Recombinant protein therapeutics cdmo market size, 2023 (USD Million)
Top 10 countries: Recombinant protein therapeutics cdmo market size, 2023 (USD Million)
Global recombinant protein therapeutics cdmo market, by region, 2023 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
